BioHiTech Global Stock Price, News & Analysis (OTCMKTS:BHTG)

$4.10 +0.01 (+0.24 %)
(As of 03/18/2018 10:04 AM ET)
Previous Close$4.10
Today's Range$4.09 - $4.30
52-Week Range$2.50 - $9.50
Volume6,828 shs
Average Volume11,690 shs
Market Capitalization$39.35 million
P/E RatioN/A
Dividend YieldN/A

About BioHiTech Global (OTCMKTS:BHTG)

BioHiTech Global, Inc. provides an environmentally friendly solution for food waste disposal. The Company, through its subsidiaries, BioHiTech America, LLC and BioHiTech Europe Limited, offers its customers various technologies integrating technological, biological and mechanical engineering solutions for the control, reduction and/or reuse of organic waste. It has a distribution license to sell, lease, use, distribute and manufacture the Eco-Safe Digester product. The Eco-Safe Digester is a data-driven, network-based mechanical/biological technology, which transforms food waste into nutrient-neutral water that can be disposed of via conventional sanitary sewer systems. The Eco-Safe Digester may be used by businesses in food service, hospitality, healthcare, government, conference centers, education centers or stadiums. Its Internet enabled system, the BioHiTech Cloud, streams data from the digesters, collects information from system users and integrates business application data.

Receive BHTG News and Ratings via Email

Sign-up to receive the latest news and ratings for BHTG and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

SectorBusiness Services


Debt-to-Equity Ratio-0.78%
Current Ratio0.17%
Quick Ratio0.12%


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$2.24 million
Price / Sales17.57
Cash FlowN/A
Price / CashN/A
Book Value($1.39) per share
Price / Book-2.95


Trailing EPS($0.97)
Net Income$-6,740,000.00
Net Margins-319.38%
Return on EquityN/A
Return on Assets-242.86%


Outstanding Shares9,600,000

BioHiTech Global (OTCMKTS:BHTG) Frequently Asked Questions

What is BioHiTech Global's stock symbol?

BioHiTech Global trades on the OTCMKTS under the ticker symbol "BHTG."

Who are some of BioHiTech Global's key competitors?

How do I buy BioHiTech Global stock?

Shares of BioHiTech Global can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is BioHiTech Global's stock price today?

One share of BioHiTech Global stock can currently be purchased for approximately $4.10.

How big of a company is BioHiTech Global?

BioHiTech Global has a market capitalization of $39.35 million and generates $2.24 million in revenue each year. The company earns $-6,740,000.00 in net income (profit) each year or ($0.97) on an earnings per share basis. BioHiTech Global employs 25 workers across the globe.

How can I contact BioHiTech Global?

BioHiTech Global's mailing address is 80 RED SCHOOLHOUSE ROAD SUITE 101, CHESTNUT RIDGE NY, 10977. The company can be reached via phone at 845-262-1081 or via email at [email protected]

MarketBeat Community Rating for BioHiTech Global (BHTG)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  49 (Vote Outperform)
Underperform Votes:  49 (Vote Underperform)
Total Votes:  98
MarketBeat's community ratings are surveys of what our community members think about BioHiTech Global and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

BioHiTech Global (OTCMKTS:BHTG) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


BioHiTech Global (OTCMKTS:BHTG) Earnings History and Estimates Chart

Earnings by Quarter for BioHiTech Global (OTCMKTS:BHTG)

BioHiTech Global (OTCMKTS BHTG) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/15/2017Q3 2017($0.27)$0.66 millionViewN/AView Earnings Details
8/15/2017Q2 2017($0.23)$0.55 millionViewN/AView Earnings Details
5/16/2017Q1 2017($0.25)$0.59 millionViewN/AView Earnings Details
3/30/2017Q4 2016($0.22)$0.71 millionViewN/AView Earnings Details
11/15/2016Q3 2016($0.20)$0.62 millionViewN/AView Earnings Details
8/15/2016Q2 2016($0.21)$0.45 millionViewN/AView Earnings Details
5/17/2016Q1 2016($0.20)$0.46 millionViewN/AView Earnings Details
4/5/2016Q4 2015($0.23)$0.58 millionViewN/AView Earnings Details
11/13/2015Q3 2015($0.20)$0.34 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


BioHiTech Global (OTCMKTS:BHTG) Earnings Estimates

No earnings estimates for this company have been tracked by


Dividend History for BioHiTech Global (OTCMKTS:BHTG)

No dividend announcements for this company have been tracked by

Insider Trades

BioHiTech Global (OTCMKTS BHTG) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 49.88%
Insider Trades by Quarter for BioHiTech Global (OTCMKTS:BHTG)

BioHiTech Global (OTCMKTS BHTG) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/16/2017John P GlaudaMajor ShareholderSell4,089$9.32$38,109.48926,713View SEC Filing  
8/7/2017John P GlaudaMajor ShareholderSell3,887$5.57$21,650.59930,450View SEC Filing  
8/4/2017John P GlaudaMajor ShareholderSell25,800$5.07$130,806.00965,368View SEC Filing  
12/30/2016Frank E. CelliCEOBuy1,100$1.92$2,112.00View SEC Filing  
(Data available from 1/1/2013 forward)


BioHiTech Global (OTCMKTS BHTG) News Headlines


SEC Filings

BioHiTech Global (OTCMKTS:BHTG) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Financials are not available for this stock.


BioHiTech Global (OTCMKTS BHTG) Stock Chart for Sunday, March, 18, 2018

Loading chart…

This page was last updated on 3/18/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.